Mankind Pharma Ltd (MANKIND)

Mankind Pharma Ltd (MANKIND) is listed on the NSE in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry. Market capitalisation: 106427.00 Cr. Figures below are as reported and are shown with their source and date.

Educational use only — GoQuant is a research tool. This page lists company facts only and is not a recommendation. Investment advice is provided by FINOME TECHNOLOGIES PVT LTD (AltQube), SEBI-registered Investment Adviser, registration no. INA000018373, under a signed advisory agreement and after a risk profile. Past performance is not indicative of future results.

Company profile

Sector
Pharmaceuticals
Industry
Pharmaceuticals & Biotechnology
Market cap (₹ Cr)
1,06,427

Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. The company is headquartered in New Delhi, Delhi and currently employs 18,468 full-time employees. The company went IPO on 2023-05-09. The firm is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The company has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 2,275.6

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E
49.11
52-week high
2,642
52-week low
1,909.7
Revenue CAGR, 3 years (%)
17.73
EPS CAGR, 3 years (%)
13.14

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Year endedRevenue (₹ Cr)PAT (₹ Cr)EPS (₹)
Mar 202614,277.641,912.9346.34
Mar 202512,207.441,990.9648.26
Mar 202410,334.771,912.947.75
Mar 20238,749.431,281.8632

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter
72.66%
FII
10.24%
DII
14.46%
Public
2.64%
Promoter shares pledged
0%

Source: finedge · as of 2026-03-31

Similar companies

Source: quantro_company_profiles · as of 2026-10-23

Recent exchange filings

Source: nse · as of 2026-10-05

Frequently asked questions

What does Mankind Pharma Ltd do?
Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. The company is headquartered in New Delhi, Delhi and currently employs 18,468 full-time employees. The company went IPO on 2023-05-09. The firm is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. The company has a portfolio of formulations in several therapeutic areas, such as anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain/analgesics, among others. Its other therapeutic areas include urology, ophthalmology, antiparasitic, stomatological, antineoplastic/immunomodulator, hepatoprotective, anti-malarial, blood-related, hormones, antiviral, sex stimulants/rejuvenators, anti-tuberculosis, parenteral and vaccines. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others.
Which sector is Mankind Pharma Ltd in?
Mankind Pharma Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.
What are Mankind Pharma Ltd's latest annual revenue and profit?
For the year ended Mar 2026: revenue 14277.64 Cr, profit after tax 1912.93 Cr.
What is the promoter holding and pledge in Mankind Pharma Ltd?
Promoter holding is 72.66%; pledged shares are 0.00% of the promoter holding.
Which companies are similar to Mankind Pharma Ltd?
Companies in the same sector of similar size: Lupin Ltd, Dr Reddy's Laboratories Ltd, Cipla Ltd, Zydus Lifesciences Ltd, Aurobindo Pharma Ltd, Laurus Labs Ltd.
Want more history and detail? Create a free account for the full price history, quarterly statements, balance sheet and cash flow.

Figures computed 2026-10-23.